SILVER SPRING Md. /PRNewswire-USNewswire/ — Today, the U.S. Food and Drug Administration approved Trogarzo (ibalizumab-uiyk), a new type of antiretroviral medication for adult patients living with HIV who have tried multiple HIV medications in the past (heavily treatment-experienced) and whose HIV infections cannot be successfully treated with other currently available therapies (multidrug resistant HIV, or MDR … Continue reading FDA approves new HIV treatment for patients who have limited treatment options